Work

Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma

Year: 2012

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2012.03.049

Authors: Paul A. Wender, Wesley C. Galliher, Neelima M. Bhat, Thomas H. Pillow, Marcia M. Bieber, Nelson N.H. Teng

Institutions: Stanford University, Stanford Medicine

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1278869635, SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORS, Synthetic Studies Related to Cancer Research/Treatment, G433345679, Pacific Ovarian Cancer Research Consortium, Synthetic Studies on Tumor Promoters and Inhibitors, G844802523, Synthetic Studies Related to Cancer Research/Treatment

OpenAlex ID: W1988812196

FWCI: 1.897

Cites: 35

Cited by: 34

Related to: 10